Post-IPO Lock-in End: 4 Stocks Fall 2.8-7.4% in Heavy Trade
Monday marked a pivotal moment for four newly listed Indian firms as IPO lock-in periods concluded, triggering declines of up to 7.4%. Heightened supply from eligible shares overshadowed positive...
Monday marked a pivotal moment for four newly listed Indian firms as IPO lock-in periods concluded, triggering declines of up to 7.4%. Heightened supply from eligible shares overshadowed positive listing premiums, leading to widespread selling pressure.
AI Finance led losses at 7.42%, following the end of its one-month lock-in. 17.6 million shares—7% of equity—entered the fray, compounding a 14.64% five-day drop and 24.29% monthly retreat.
Fractal Analytics fell 4.35% (3.98% intraday at ₹764.35), with 6.9 million shares (4% equity) unlocked. The stock lags 12% behind its ₹900 IPO level.
Park Medi World declined 3.2% on 8.5 million shares (2% equity) availability, and Nephrocare Health Services eased 2.8% with 2.8 million shares (3% equity) freed up.
A deeper trend emerges from Nuvama Wealth Management data: Lock-ins for 88 recent IPOs' early investors unwind through June 2026, unlocking $72 billion (₹6.6 lakh crore) in equity. This pipeline threatens upward trajectories for many listings.
Investors should view these dips through a strategic lens—lock-in expiries test liquidity but often stabilize post-event. With robust economic backdrops, selective accumulation in quality names could yield gains as markets recalibrate.